Eur Rev Med Pharmacol Sci 2023; 27 (6): 2619-2623
DOI: 10.26355/eurrev_202303_31798

Preferred treatment approach to De Quervain Tenosynovitis in nursing women: conservative management or surgery?

B. Akar, M.O. Yücel

Department of Orthopedics and Traumatology, Sakarya Yenikent State Hospital, Sakarya, Turkey. drbedrettin@gmail.com


OBJECTIVE: We aimed to show the effectiveness of different treatment methods in the prevention of clinical symptoms and recurrence of De Quervain Tenosynovitis (DQT), which is often seen in nursing women.

PATIENTS AND METHODS: Three different treatment methods were used in 124 patients, all of whom were breastfeeding women who visited our clinic between 2017-2022 with a positive Finkelstein test and DQT. Group I comprised 56 patients who underwent surgical treatment under local anesthesia, Group II, 41 patients who received steroid injections as conservative treatment, and Group III, 27 patients who received wrist splints. The patient files of all groups were reviewed retrospectively, and the effects of the treatment methods on clinical symptoms and recurrence were investigated in patients who were followed up at the 2nd, 4th and 8th weeks.

RESULTS: The recurrence rate of Group I patients, which were treated surgically, was significantly lower than that of Group II and III (p=0.0001). Among those who received conservative treatment, patients in Group II had significantly lower recurrence rates than those in Group III. At the 8th week of treatment, clinical symptoms had improved by 96.45%, 58.5%, and 7.4% in Groups I, II, and III, respectively.

CONCLUSIONS: It is thought that the repetitive movements made during baby care and the edema that develops in breastfeeding women prepare the ground for DQT. Surgery is the most effective treatment method for the improvement of clinical symptoms and prevention of recurrence.

Free PDF Download

To cite this article

B. Akar, M.O. Yücel
Preferred treatment approach to De Quervain Tenosynovitis in nursing women: conservative management or surgery?

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 6
Pages: 2619-2623
DOI: 10.26355/eurrev_202303_31798